Drug resistance to nelarabine in leukemia cell lines might be caused by reduced expression of deoxycytidine kinase through epigenetic mechanisms
Keishi Yoshida, Atsushi Fujita, Hidehiko Narazaki, Takeshi Asano, Yasuhiko Itoh
Topics & Concepts
Deoxycytidine kinaseVorinostatCancer researchDNA methylationBiologyK562 cellsLeukemiaDecitabineDeoxycytidineChemistryMolecular biologyHistone deacetylaseHistoneBiochemistryGene expressionCancerImmunologyGeneticsGemcitabineGeneAcute Lymphoblastic Leukemia researchHistone Deacetylase Inhibitors ResearchLung Cancer Research Studies